Article summary
This systematic review (2026) of 44 clinical trials (1,537 participants) examined psychological treatment frameworks accompanying psilocybin, LSD and DMT for psychiatric symptoms. Most trials used preparation, dosing and integration, but psychological approaches and non-dosing sessions (0β17) varied widely; the authors call for trials that isolate the contribution of psychological components.
Continue to the original publication for the complete article.